Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$20.49 - $39.72 $4.4 Million - $8.53 Million
-214,862 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$28.19 - $46.6 $3,298 - $5,452
117 Added 0.05%
214,862 $7.95 Million
Q4 2021

Feb 03, 2022

SELL
$41.2 - $73.6 $30,694 - $54,831
-745 Reduced 0.35%
214,745 $9.77 Million
Q3 2021

Oct 19, 2021

SELL
$59.15 - $91.99 $818,576 - $1.27 Million
-13,839 Reduced 6.03%
215,490 $13.7 Million
Q2 2021

Aug 02, 2021

BUY
$63.02 - $95.11 $1.71 Million - $2.58 Million
27,147 Added 13.43%
229,329 $21 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $1.88 Million - $3.13 Million
-32,695 Reduced 13.92%
202,182 $13.8 Million
Q4 2020

Feb 05, 2021

SELL
$41.43 - $77.09 $10 Million - $18.7 Million
-242,387 Reduced 50.79%
234,877 $17 Million
Q3 2020

Nov 13, 2020

SELL
$30.88 - $37.94 $864,022 - $1.06 Million
-27,980 Reduced 5.54%
477,264 $18.1 Million
Q2 2020

Aug 03, 2020

SELL
$18.95 - $35.43 $3.78 Million - $7.06 Million
-199,290 Reduced 28.29%
505,244 $17.9 Million
Q1 2020

May 06, 2020

BUY
$13.94 - $28.25 $3.69 Million - $7.48 Million
264,827 Added 60.23%
704,534 $15.4 Million
Q4 2019

Feb 04, 2020

SELL
$19.24 - $28.41 $388,859 - $574,194
-20,211 Reduced 4.39%
439,707 $9.48 Million
Q3 2019

Nov 12, 2019

BUY
$20.03 - $40.08 $430,865 - $862,160
21,511 Added 4.91%
459,918 $10.4 Million
Q2 2019

Jul 26, 2019

BUY
$25.78 - $39.77 $2.11 Million - $3.26 Million
81,932 Added 22.98%
438,407 $15.8 Million
Q1 2019

May 07, 2019

BUY
$22.09 - $39.21 $7.87 Million - $14 Million
356,475 New
356,475 $11.2 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.2B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Redwood Investments, LLC Portfolio

Follow Redwood Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investments, LLC with notifications on news.